•
Sep 30, 2014

EyePoint Pharmaceuticals Q1 2015 Earnings Report

Total Revenue
$25.3M
Previous year: $597K
+4137.9%
EPS
$6.7
Previous year: -$1.4
-578.6%
Gross Profit
$22.5M
Previous year: -$1.91M
-1281.1%
Cash and Equivalents
$11.4M
Previous year: $14.5M
-21.7%
Total Assets
$43.7M
Previous year: $22.7M
+92.4%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals